Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Mangalam Drugs & Organics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-381.02	-444	67.21	-90.72	12.7	196.58
Depreciation & Amortization	157.11	166.11	155.16	65.72	104.36	97.78
Other Amortization	16.12	16.12	10.91	9.2	5.53	4.71
Loss (Gain) From Sale of Assets	1.51	-0.41	-0.74	0.7	0.03	1.74
Loss (Gain) From Sale of Investments	-	-	-	-	-	0.12
Other Operating Activities	119.63	100.74	120.46	193.32	138.97	112.05
Change in Accounts Receivable	-158.76	-12.24	-111.28	10.47	-0.43	78.22
Change in Inventory	206.63	360.28	-151.62	168.88	-203.61	-585.18
Change in Accounts Payable	81.89	-222.59	249.86	-199.04	425.26	111.52
Change in Other Net Operating Assets	155.25	77.77	85.99	-119.41	-87.58	239.55
Operating Cash Flow	198.36	41.78	425.94	39.13	395.23	257.09
Operating Cash Flow Growth	7.84%	-90.19%	988.64%	-90.10%	53.73%	-6.68%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-78.85	-118.99	-202.01	-118.33	-279.14	-276.69
Sale of Property, Plant & Equipment	2.59	1.74	7.28	0.05	57.41	1.36
Investment in Securities	0.02	-	-	-0	-	2.07
Other Investing Activities	-	0	0	0	0.01	0.01
Investing Cash Flow	-76.25	-117.25	-194.72	-118.27	-221.72	-273.26

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	236.03	-	169.4	24.71	-
Long-Term Debt Issued	-	-	-	-	-	182.27
Total Debt Issued	156.93	236.03	-	169.4	24.71	182.27
Short-Term Debt Repaid	-	-	-26.59	-	-	-40.85
Long-Term Debt Repaid	-	-17.35	-41.21	-44.53	-63.37	-
Total Debt Repaid	-157.49	-17.35	-67.8	-44.53	-63.37	-40.85
Net Debt Issued (Repaid)	-0.56	218.68	-67.8	124.87	-38.66	141.41
Other Financing Activities	-146.98	-162.08	-149.33	-72.6	-127.51	-111.62
Financing Cash Flow	-147.54	56.59	-217.12	52.27	-166.17	29.79

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	-	-	-	0	-
Net Cash Flow	-25.42	-18.88	14.09	-26.88	7.34	13.63

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	119.51	-77.22	223.93	-79.2	116.09	-19.6
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	4.56%	-3.33%	7.05%	-2.16%	3.14%	-0.43%
Free Cash Flow Per Share	7.55	-4.88	14.15	-5.00	7.33	-1.24
Levered Free Cash Flow	251.95	50.39	116.02	-67.72	-43.82	-243.32
Unlevered Free Cash Flow	319.24	127.13	185.9	-2.67	11.93	-198.3

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	71.36	162.08	149.33	72.6	127.51	111.62
Cash Income Tax Paid	2.91	2.91	0.83	0.92	-0.26	88.08
Change in Working Capital	285.01	203.22	72.95	-139.11	133.64	-155.88

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error